Publication | Closed Access
Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review
10
Citations
0
References
2020
Year
We show that recurrence of FSGS can be controlled long term with IA plus rituximab. However, some patients remained dependent on IA.